Waverley Pharma Inc (WAVE) — Cash Flow Reinvestment Rate
Latest as of September 2024:
13.09x
Waverley Pharma Inc (WAVE) has a Cash Flow Reinvestment Rate of 13.09x as of September 2024, reinvesting CA$611.65K (capex CA$0.00 plus investments CA$-611.65K) from operating cash flow of CA$46.72K. See WAVE financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
13.09x
(Capex + Investments) / Operating CF
Total Reinvested
CA$611.65K
Capex + Investments
Operating Cash Flow
CA$46.72K
CAD
Capital Expenditures
CA$0.00
CAD
Annual Cash Flow Reinvestment Rate for Waverley Pharma Inc (None–None)
Year-by-year capital reinvestment analysis for Waverley Pharma Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Waverley Pharma Inc.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow